Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
62,990.07 +3,846.51 (+6.50%) CMC Crypto 200
1,363.63 +86.66 (+6.79%)
Daiichi Sankyo Company, Limited (DSNKY)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 03:59PM EDT
| Previous close | 35.48 |
| Open | 36.84 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 35.49 - 36.84 |
| 52-week range | 23.72 - 37.57 |
| Volume | |
| Avg. volume | 178,054 |
| Market cap | 68.762B |
| Beta (5Y monthly) | 0.29 |
| PE ratio (TTM) | 54.33 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.24 (0.69%) |
| Ex-dividend date | 28 Sept 2023 |
| 1y target est | N/A |
- Yahoo Finance
AstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain'
AstraZeneca CEO Pascal Soriot joined Yahoo Finance to discuss the company's earnings today.
- Zacks
Atossa (ATOS) Reports Positive Results From EVANGELINE Study
Atossa (ATOS) unveils positive results from its phase 2 EVANGELINE clinical study, which shows that (Z)-endoxifen can reduce the growth of ER+ breast cancer.
- Zacks
Merck (MRK) Begins Phase II/II Ovarian Cancer Study on ADC Drug (Revised)
Merck's (MRK) phase II/III study called REJOICE-Ovarian01 study will evaluate the efficacy of raludotatug deruxtecan in patients with platinum-resistant ovarian cancer.
© 2024 Yahoo. All rights reserved.